Bruker Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Frank H. Laukien
- Full Time Employees
- 11,396
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Address
- 40 Manning Road Billerica MA United States of America 01821
- IPO Date
- Aug 8, 1996
- CIK
- 0001109354
- Website
- bruker.com
- Similar Companies
- Business
- Bruker Corporation stands as a prominent global entity in the realm of scientific instrumentation, dedicated to the development, manufacturing, and distribution of advanced analytical and diagnostic technologies. The company furnishes high-performance solutions for exploring both life and materials at the molecular, cellular, and microscopic scales. Its comprehensive portfolio supports cutting-edge research and applied analysis across diverse fields such as proteomics, spatial and single-cell biology, preclinical imaging, clinical microbiology, and materials science. Through innovation in areas like magnetic resonance, mass spectrometry, and various microscopy techniques, Bruker empowers customers in academic, pharmaceutical, biotechnology, and industrial sectors worldwide to achieve deeper insights and enhance productivity.
Company News
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Investors Heavily Search Berkshire Hathaway Inc. (BRK.B): Here is What You Need to Know
Bruker Corporation to Present at Upcoming Investor Conferences
Berkshire Hathaway B (BRK.B) Down 3% Since Last Earnings Report: Can It Rebound?
Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?
Warren Buffett Set Berkshire Hathaway Up for Years: Top 5 Stocks Yield $589 Million Each Quarter
Berkshire Hathaway: Finally Using Its Cash Pile
Berkshire Hathaway 13F Preview: What Stock Moves Did Buffett Successor Greg Abel Make?
Moving Past Buffett: Berkshire Successor Puts Stamp on Portfolio With $1.2 Billion Gain on Three New Stocks
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
Berkshire Hathaway Stock Pop After Q2 EPS Surprise
BRK.B Q2 Earnings & Revenues Rise Year Over Year on Diversified Growth
Michael Burry's Latest Call: Berkshire Isn't Warren Buffett Anymore
Investors Shrug Off Geopolitical Risk, BRK/B Beats & META Muse Glimmer Release
Berkshire Hathaway: Finally Spending That Enormous Cash Hoard
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
Berkshire Hathaway Inc. News Release
Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript
Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Bruker Q2 Earnings Call Highlights